deoxypyridinoline has been researched along with Polycystic Ovary Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aktas, A; Aral, Y; Berberoglu, Z; Fidan, Y; Yazici, AC | 1 |
| Adami, S; Castello, R; Gatti, D; Moghetti, P; Tosi, F; Zamberlan, N | 1 |
2 other study(ies) available for deoxypyridinoline and Polycystic Ovary Syndrome
| Article | Year |
|---|---|
Association of plasma GDF-9 or GDF-15 levels with bone parameters in polycystic ovary syndrome.
Topics: Adult; Amino Acids; Anthropometry; Body Mass Index; Bone Density; Case-Control Studies; Energy Metabolism; Female; Growth Differentiation Factor 15; Growth Differentiation Factor 9; Hirsutism; Homeostasis; Hormones; Humans; Obesity; Osteocalcin; Polycystic Ovary Syndrome | 2015 |
Effect of hyperandrogenism and menstrual cycle abnormalities on bone mass and bone turnover in young women.
Topics: Adolescent; Adult; Amenorrhea; Amino Acids; Analysis of Variance; Biomarkers; Bone Density; Bone Remodeling; Collagen; Collagen Type I; Female; Hirsutism; Humans; Hydroxyproline; Osteocalcin; Peptides; Polycystic Ovary Syndrome; Regression Analysis | 1998 |